Lp(a) in the Pathogenesis of Aortic Stenosis and Approach to Therapy with Antisense Oligonucleotides or Short Interfering RNA.

Di Costanzo, Assunta; Indolfi, Ciro; Franzone, Anna; Esposito, Giovanni; Spaccarotella, Carmen Anna Maria

Di Costanzo, Assunta; Indolfi, Ciro; Franzone, Anna; Esposito, Giovanni; Spaccarotella, Carmen Anna Maria.

Di Costanzo A; Division of Cardiology, Cardiovascular Research Center, University Magna Graecia Catanzaro, 88100 Catanzaro, Italy.
Indolfi C; Division of Cardiology, Cardiovascular Research Center, University Magna Graecia Catanzaro, 88100 Catanzaro, Italy.
Franzone A; Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy.
Esposito G; Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy.
Spaccarotella CAM; Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy.

Int J Mol Sci ; 24(19)2023 Oct 06.

Article en En | MEDLINE | ID: mdl-37834387

Asunto(s)

Estenosis de la Válvula Aórtica; Proproteína Convertasa 9; Anciano; Humanos; Válvula Aórtica/patología; ARN Interferente Pequeño; Oligonucleótidos Antisentido/uso terapéutico; Inteligencia Artificial; Estenosis de la Válvula Aórtica/etiología; Estenosis de la Válvula Aórtica/genética; Lipoproteína(a)/genética; Factores de Riesgo

Palabras clave

AVR; Lp(a); TAVI; aortic valve stenosis; artificial intelligence; calcification; dyslipidemia; inflammation; olpasiran; pelacarsen

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estenosis de la Válvula Aórtica / Proproteína Convertasa 9 Límite: Aged / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google